ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

26.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 118.50
  • 52 Week Low: 25.30
  • Currency: UK Pounds
  • Shares Issued: 57.06m
  • Volume: 75,463
  • Market Cap: 15.12m
  • RiskGrade: 394

ReNeuron Group Overview

ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2807.5% -1636.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 37.1 21.6
Pr/Book 1.5  
Latest F'cast
Revenue 53.8% 71.5%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ReNeuron Group Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 0.04 (20.97) (54.23)p n/a n/a n/a n/a 0.0%
31-Mar-19 0.05 (17.23) (44.11)p n/a n/a n/a n/a 0.0%
31-Mar-20 6.07 (13.86) (34.96)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.26 (13.41) (29.00)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.40 (11.06) (17.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ReNeuron Group Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 0.69 (11.22) (16.66)p n/a n/a n/a n/a 0.0%
31-Mar-24 0.66 (11.75) (17.38)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

ReNeuron Group Company Announcements

Directorate Change 01-Aug-2022 07:00 RNS
Grant of Options 15-Jul-2022 07:00 RNS
Share Purchase by a Director 14-Jul-2022 07:00 RNS

Latest ReNeuron Group Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

ReNeuron Group Market Data

Currency UK Pounds
Share Price 26.50p
Change Today 0.50p
% Change 1.92 %
52 Week High 118.50
52 Week Low 25.30
Volume 75,463
Shares Issued 57.06m
Market Cap 15.12m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.10% above the market average20.10% above the market average20.10% above the market average20.10% above the market average20.10% above the market average
10.71% below the sector average10.71% below the sector average10.71% below the sector average10.71% below the sector average10.71% below the sector average
Price Trend
91.98% below the market average91.98% below the market average91.98% below the market average91.98% below the market average91.98% below the market average
78.12% below the sector average78.12% below the sector average78.12% below the sector average78.12% below the sector average78.12% below the sector average
Income Not Available
Growth
18.41% above the market average18.41% above the market average18.41% above the market average18.41% above the market average18.41% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ReNeuron Group Dividends

No dividends found

Trades for 15-Aug-2022

Time Volume / Share Price
12:43 878 @ 27.55p
12:37 2,500 @ 26.90p
12:36 10,402 @ 28.00p
12:25 2,000 @ 25.62p
11:30 1,600 @ 25.75p

ReNeuron Group Key Personnel

CFO Catherine Isted

Top of Page